Key Takeaways Henry Schein expanded its vVARDIS deal, securing exclusive U.S. distribution of Curodont from 2026. HSIC shares inched higher as the partnership is expected to strengthen the company's Dental business. The expansion lets Henry Schein reach general, orthodontic, and pediatric care with wider Curodont access. Henry Schein, Inc. (HSIC) recently expanded its agreement with vVARDIS and gained the exclusive U.S. distribution rights for the drill-free Curodont Repair Fluoride Plus (Curodont) product ...